124 related articles for article (PubMed ID: 38556102)
1. Optimized production of full-length PCV2d virus-like particles in Escherichia coli: A cost-effective and high-yield approach for potential vaccine antigen development.
Zhang C; He F; Li N; Du W; Wen J; Wu X; Shi J; Li C; Liu C; Xu S; Han H; Hrabchenko N; Han X; Li J
Microb Pathog; 2024 May; 190():106630. PubMed ID: 38556102
[TBL] [Abstract][Full Text] [Related]
2. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
[TBL] [Abstract][Full Text] [Related]
3. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.
Wu PC; Chen TY; Chi JN; Chien MS; Huang C
J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354
[TBL] [Abstract][Full Text] [Related]
4. Reduction of Postweaning Multisystemic Wasting Syndrome-Associated Clinical Symptoms by Virus-Like Particle Vaccine Against Porcine Parvovirus and Porcine Circovirus Type 2.
Liu G; Qiao X; Chang C; Hua T; Wang J; Tang B; Zhang D
Viral Immunol; 2020; 33(6):444-456. PubMed ID: 32255758
[TBL] [Abstract][Full Text] [Related]
5. Efficient application of a baculovirus-silkworm larvae expression system for obtaining porcine circovirus type 2 virus-like particles for a vaccine.
He Q; Cao Z; Wang P; Lu Q; Zheng H; Sun J
Arch Virol; 2020 Oct; 165(10):2301-2309. PubMed ID: 32757056
[TBL] [Abstract][Full Text] [Related]
6. Generation and immunogenicity assessment of ELPylated virus-like particles of porcine circovirus type 2.
Li Y; Wang Y; Cheng J; Zhou X; Lu H; Zhang X; Xia X; Sun H
Virol J; 2020 Jun; 17(1):72. PubMed ID: 32517704
[TBL] [Abstract][Full Text] [Related]
7. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts.
Bucarey SA; Noriega J; Reyes P; Tapia C; Sáenz L; Zuñiga A; Tobar JA
Vaccine; 2009 Sep; 27(42):5781-90. PubMed ID: 19664739
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of a truncated form of flagellin (TFlg) into porcine circovirus type 2 virus-like particles enhances immune responses in mice.
Liu X; Liu Y; Zhang Y; Zhang F; Du E
BMC Vet Res; 2020 Feb; 16(1):45. PubMed ID: 32028949
[TBL] [Abstract][Full Text] [Related]
9. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of immunogenic recombinant virus-like particles of porcine circovirus type 2 expressed in silkworm pupae.
Masuda A; Lee JM; Miyata T; Sato T; Hayashi S; Hino M; Morokuma D; Karasaki N; Mon H; Kusakabe T
J Gen Virol; 2018 Jul; 99(7):917-926. PubMed ID: 29851377
[TBL] [Abstract][Full Text] [Related]
11. Generation of E. coli-derived virus-like particles of porcine circovirus type 2 and their use in an indirect IgG enzyme-linked immunosorbent assay.
Zhang Y; Wang Z; Zhan Y; Gong Q; Yu W; Deng Z; Wang A; Yang Y; Wang N
Arch Virol; 2016 Jun; 161(6):1485-91. PubMed ID: 26973229
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Immune Responses to the PCV2 Replicase-Capsid and Capsid Virus-Like Particle Vaccines in Mice.
Jung BK; Kim HR; Lee YH; Jang H; Chang KS
J Microbiol Biotechnol; 2019 Mar; 29(3):482-488. PubMed ID: 30609882
[TBL] [Abstract][Full Text] [Related]
13. A candidate DNA vaccine encoding a fusion protein of porcine complement C3d-P28 and ORF2 of porcine circovirus type 2 induces cross-protective immunity against PCV2b and PCV2d in pigs.
Hou Z; Wang H; Feng Y; Li Q; Li J
Virol J; 2019 May; 16(1):57. PubMed ID: 31046793
[TBL] [Abstract][Full Text] [Related]
14. Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B.
Hu G; Wang N; Yu W; Wang Z; Zou Y; Zhang Y; Wang A; Deng Z; Yang Y
Vaccine; 2016 Apr; 34(16):1896-903. PubMed ID: 26930366
[TBL] [Abstract][Full Text] [Related]
15. PCV cap proteins fused with calreticulin expressed into polymers in Escherichia coli with high immunogenicity in mice.
Liu C; Liu Y; Feng H; Zhao B; Chen Y; Huang H; Wang P; Deng R; Zhang G
BMC Vet Res; 2020 Aug; 16(1):313. PubMed ID: 32854700
[TBL] [Abstract][Full Text] [Related]
16. Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-γ in mice.
Wang YP; Liu D; Guo LJ; Tang QH; Wei YW; Wu HL; Liu JB; Li SB; Huang LP; Liu CM
Vaccine; 2013 Jan; 31(5):833-8. PubMed ID: 23219694
[TBL] [Abstract][Full Text] [Related]
17. Efficient production of porcine circovirus virus-like particles using the nonconventional yeast Kluyveromyces marxianus.
Duan J; Yang D; Chen L; Yu Y; Zhou J; Lu H
Appl Microbiol Biotechnol; 2019 Jan; 103(2):833-842. PubMed ID: 30421111
[TBL] [Abstract][Full Text] [Related]
18. The Carboxyl Terminus of the Porcine Circovirus Type 2 Capsid Protein Is Critical to Virus-Like Particle Assembly, Cell Entry, and Propagation.
Zhan Y; Yu W; Cai X; Lei X; Lei H; Wang A; Sun Y; Wang N; Deng Z; Yang Y
J Virol; 2020 Apr; 94(9):. PubMed ID: 32075927
[TBL] [Abstract][Full Text] [Related]
19. Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli.
Yin S; Sun S; Yang S; Shang Y; Cai X; Liu X
Virol J; 2010 Jul; 7():166. PubMed ID: 20646322
[TBL] [Abstract][Full Text] [Related]
20. Production of Escherichia coli-based virus-like particle vaccine against porcine circovirus type 2 challenge in piglets: Structure characterization and protective efficacy validation.
Xi X; Mo X; Xiao Y; Yin B; Lv C; Wang Y; Sun Z; Yang Q; Yao Y; Xuan Y; Li X; Yuan YA; Tian K
J Biotechnol; 2016 Apr; 223():8-12. PubMed ID: 26907669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
